Contraceptive Drugs Market Overview:
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during the forecast period. Contraception is a method to prevent unwanted pregnancy, control birth rate, and reduce the risk of sexually transmitted diseases (STDs). Contraception involves the use of drugs in the form of oral pills, injectable contraceptives, and topical contraceptives. These drugs are used among women of childbearing age after puberty and before menopause, that is, between 15 and 44 years of age. Contraceptive drugs are used by a set of end users to prevent pregnancy & STIs and for birth control & family planning. Increase in concerns about family planning and necessity to prevent unintended pregnancy are some of the major factors driving the growth of the global contraceptive drugs market. Furthermore, upsurge in the use of contraception among young women and increase in higher educational attainment promote the market growth. Furthermore, health problems allied with teenage pregnancies, surge in awareness regarding modern contraception methods, and increase in the usage of oral pills as a crucial technique to avert unplanned pregnancy are expected to propel the growth of the market in the years to come. However, health risks associated with the use of contraceptives, accessibility of alternate contraceptive methods, and less social acceptance negatively impact the contraceptive drugs market growth.
COVID-19 impact
Nationwide lockdown imposed across the globe in an effort to combat COVID-19 pandemic has adversely affected the contraceptive market. Most of the women are unable to access and purchase pills or visit a healthcare center for receiving an injectable. Moreover, contraceptive drug manufacturers were facing newer challenges with inconsistent and interrupted supply chain activities and availability of human resources. However, as the restrictions are easing globally, the market is expected to gain traction in coming years, owing to increase in online availability of contraceptive drugs as well as pharmacies. Manufacturers are likely to face challenges in coping up with demand and supply side.
Product segment review
Depending on product, the contraceptive drugs are categorized into oral (pills), injectable, and topical contraceptives. Oral contraceptive drugs or oral contraceptive pills segment accounted for over 85.36% share in the global contraceptive drugs market in 2019. Oral pills are the most common type of reversible contraception used worldwide. Higher effectiveness and better convenience have made them a preferred form of contraception over the past few years. In addition, large consumer base and proactive government initiatives to cater the unmet needs of contraception have boosted the market growth. However, the injectable contraceptives segment is estimated to register a CAGR of 8.0% during the forecast period, due to rise in awareness of injectables available in the market and growth in population.
By Product
Oral Contraceptive Drugs segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Age group segment review
On the basis of age group, women in the age group of 15–24 years dominated the global contraceptive drugs market in 2019. This is attributed to the augmented use of contraceptives among teenagers, early maturity among teenage girls, and increase in demand for contraceptives. Conversely, women aged above 44 years are the least contributors to the contraceptive drugs market growth, owing to the menopause in women at the age 44 years and above.
By Age Group
15-24 years segment is projected as one of the most lucrative segment.
End-user segment review
By end user, the market is classified into homecare, hospitals, and clinics. The homecare segment accounted for the largest share in the global contraceptive market, owing to the wide consumption of oral pills to prevent unplanned pregnancy and STIs. Contraceptives that are preferred in home settings comprise oral pills, topical contraceptives, and contraceptive patches. These contraceptives help to reduce the risk of pregnancy and chance of getting STIs. Increase in use of contraceptive drugs at home has improved health-related outcomes such as maternal & infant mortality; reduced the risk of STI such as HIV, hepatitis B, syphilis, and gonorrhea; and improved economic outcomes of a family.
By End User
Household segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Region segment review
North America accounted for majority of the share in the global contraceptive drugs market in 2019. This region is projected to uphold its lead throughout the analysis period, owing to rise in awareness regarding contraceptive pills, surge in adoption of modern contraceptive drugs, and alarming rise in prevalence of sexually transmitted diseases such as HIV/AIDS. U.S. accounts for the significant share in the overall North American contraceptive drugs market. Asia-Pacific is anticipated to grow at the fastest pace during the forecast period, due to presence of large population base and proactive initiatives of governmental organizations for birth control and awareness within the developing countries. In addition, availability of cost-effective contraceptive drugs in this region proposes profitable opportunities to contraceptive drug manufacturers. Launch of awareness programs by government agencies and other regulatory bodies to increase the homecare usage of contraceptive drugs drives the market growth in the Asia-Pacific and LAMEA.
By Region
North America was holding a dominant position in 2019 and would continue to maintain the lead over the analysis period.
The key players profiled in this report include Agile Therapeutics, Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG and Teva Pharmaceutical Industries Ltd. Other players operating in the market are HLL Lifecare ltd, and Sanofi.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current contraceptive drugs market trends and forecast estimations from 2019 to 2027, which assists to identify the prevailing contraceptive drugs market opportunities.
- An in-depth contraceptive drugs market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- Region-wise and country-wise market conditions are comprehensively analyzed in this report.
- The projections in this report are made by analyzing the current trends and future contraceptive drugs market potential from 2020 to 2027, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the contraceptive drugs market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of global contraceptive drugs market.
Contraceptive Drugs Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Age Group |
|
 By End User |
|
 By Region |
|
 Key Market Players | Teva Pharmaceutical Industries Ltd., Piramal Healthcare, Bayer AG, Agile Therapeutics, Pfizer Inc., Johnson & Johnson, Novartis AG, Allergan Plc., GlaxoSmithKline Plc, Mylan N.V. |
Analyst Review
The utilization rate of contraceptive drugs is expected to increase due to alarming rise in incidence of sexually transmitted diseases (STDs) and need for birth control. The contraceptive drugs market has piqued the interest of healthcare providers, due to the benefits offered by these drugs to prevent unwanted pregnancy.
Homecare users reported for a substantial share in the contraceptive drugs market, due to the use of user-friendly contraceptive methods such as pills and topical contraceptives. Contraceptive drug manufacturers have focused on marketing novel contraceptives for homecare users through various media such as television and internet.
Research and development on contraceptive drugs have led to the introduction of advanced contraceptive options for population control, transmission of STDs, and prevention of unwanted pregnancy. Rise in incidence of STDs, increase in number of unwanted pregnancies, and emphasis on the prevention of immature pregnancy & abortions are some of the driving factors of the market. However, social, ethical, and religious barriers and beliefs hamper the market growth. Currently, the oral contraceptive or pill segment has the largest revenue share in the contraceptive drugs market, followed by injectable contraceptives.
Asia-Pacific is expected to be the most promising regional market for contraceptive drugs. Government organizations and NGOs have taken initiatives toward population control, prevention of unintentional pregnancies, and transmission of STDs among low-income groups. In addition, emerging markets have been gaining importance due the growing population in this region. Rapid growth in shipments of these drugs was observed to provide improved healthcare services in the emerging nations, especially Japan. This is expected to offset the challenging conditions in the mature markets such as North America and Europe. North America is expected to dominate the global contraceptive drugs market during the forecast period, followed by Europe.
The key trends in the contraceptive drugs Market are increase in awareness regarding STDs among population and avoid unwanted pregnancy among women
No, there is no value chain analysis provided in the contraceptive drugs Market report
The top companies that hold the market share in contraceptive drugs Market are Agile Therapeutics, Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Merck & Co., Inc., Mylan N.V., Pfizer Inc.
The total market value of contraceptive drugs Market is $14,324.12 million in 2019
The forecast period in the report is from 2020 to 2027
The market value of contraceptive drugs Market in 2020 was $15,255.18 Million
The base year for the report is 2019
Yes, contraceptive drugs companies are profiled in the report
Loading Table Of Content...
